corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items about drug promotion published in the WHO Essential Drugs Monitor

2002 Issue 31

Mintzes B. Women and drug promotion: "the essence of womanhood is now in tablet form”. Essent Drugs Monit 2002;(31):12-13
first page | second page

Europe: call to leave current advertising regulations intact. Essent Drugs Monit 2002;(31):14-15
first page | second page

New report on French sales representatives’ visits. Essent Drugs Monit 2002;(31):15
on bottom left of page

FDA reviews its direct-to-consumer advertising policy. Essent Drugs Monit 2002;(31):15
on bottom right of page

Wilkes M, Hoffman J. An innovative approach to educating medical students about pharmaceutical promotion. Essent Drugs Monit 2002;(31):16-17
first page | second page

New WHO/NGO database on drug promotion launched. Essent Drugs Monit 2002;(31):18-19
first page | second page

Mintzes B. Direct-to-consumer prescription drug advertising: is there evidence of health benefits? Essent Drugs Monit 2002;(31):19-20
first page | second page

Roughead LE. The Australian Pharmaceutical Manufacturers Association Code of Conduct: guiding the promotion of prescription medicines. Essent Drugs Monit 2002;(31):20-21
first page | second page

Gopalakrishnan S, Murali R. India: campaign to tackle unethical promotion. Essent Drugs Monit 2002;(31):22
top of page

Doctors and drug companies: analysing a complex relationship. Essent Drugs Monit 2002;(31):22
bottom of page

1997 Issue 24

Mansfield P, Lexchin J. MaLAM: networking for scientific integrity in drug promotion. Essent Drugs Monit 1997;(24):5
one page

1994 Issue 17 Theme Issue about Drug Promotion

Editorial. Promoting drugs ethically. Drugs Monit 1994;(17):1
one page

Mansfield P. MaLAM: Encouraging trustworthy drug promotion. Drugs Monit 1994;(17):6
first page | second page

CIOMS/WHO meeting on Ethical Criteria for Medicinal Drug Promotion. Drugs Monit 1994;(17):18
one page

OTA study reports on drug promotion in developing countries. Drugs Monit 1994;(17):19
top of page

Chirac P, Pikon A, Poinsignon Y, Vitry A. Drug marketing in French-speaking African countries. Drugs Monit 1994;(17):20-21
first page | second page

Bardelay D. French doctors report on sales representatives' visits. Drugs Monit 1994;(17):21
one page

Loes van Staa A. A mutual bond: pharmaceutical representatives and doctors in the Philippines. Drugs Monit 1994;(17):22-23
first page | second page on bottom of page

Harvey K, Black F. Prescribing rationally not fashionably. Drugs Monit 1994;(17):23
top of page

Editor's Note. Drugs Monit 1994;(17):24
left of page

McArtney R. Hitch-hikers guide to promotional drug literature. Drugs Monit 1994;(17):24
right of page

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963